Table 2 Drug management (n=63*) Table 2 Drug management (n=63*) Table 2 Drug management (n=63*) Table 2 Drug management (n=63*) Table 2 Drug management (n=63*)
Baseline 3 months 6 months 12 months
n=63 n=63 n=62 n=62
Antiarrhythmic Therapy
Class I 33 (52.4) 29 (46) 16 (25.8) 13 (21)
Class II 26 (41.3) 25 (39.7) 25 (40.3) 25 (40.3)
Class III 14 (22.2) 13 (20.6) 8 (12.9) 5 (8.1)
Class IV 0 (0) 0 (0) 0 (0) 0 (0)
Without Therapy 10 (15.9) 13 (20.6) 29 (46.8) 29 (46.8)
Anticoagulation/Antiagregation Therapy
Vitamin K Antagonist 17 (27) 18 (28.6) 16 (25.8) 13 (21)
Direct Oral Anticoagulants 36 (57.1) 37 (58.8) 31 (50) 22 (35.5)
Acetylsalicylic Acid 4 (6.3) 4 (6.3) 4 (6.5) 4 (6.4)
Without Therapy 6 (9.5) 4 (6.3) 11 (17.7) 23 (37.1)
Missing event data from subject who died before 6M FU, values are n (%) * Missing event data from subject who died before 6M FU, values are n (%) * Missing event data from subject who died before 6M FU, values are n (%) * Missing event data from subject who died before 6M FU, values are n (%) * Missing event data from subject who died before 6M FU, values are n (%)